IRVINE, Calif., June 15, 2023 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the company will present four posters at the 2023 Mitochondrial Medicine Symposium. The event, which is hosted by the United Mitochondrial… Continue reading Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
